Offline reinforcement learning (RL) offers considerable promise for optimizing ICU treatment decisions, yet standard evaluation metrics Mean Squared Error (MSE) and Fitted Q-Evaluation (FQE) assess only behavioral imitation and cannot detect Toxic Mimicry, a failure mode in which agents replicate harmful patterns such as treatment withdrawal during comfort-care transitions. Using the MIMIC-III database, we propose the Counterfactual Clinical Audit (CCA) framework, which stress-tests RL agents through physiological perturbations anchored in Surviving Sepsis Campaign (SSC) guidelines. We audit a Medical Decision Transformer (MedDT) and a Historical Causal Transformer (HCT-RL), the latter employing Causal Action Shielding, propensity-based importance weighting, and Conservative Q-Learning. CCA reveals that MedDT paradoxically reduces vasopressor dosage as lactate escalates, contradicting resuscitation guidelines, while HCT-RL maintains physiologically consistent responses. These findings expose a systemic misalignment between statistical fit and clinical safety, supporting counterfactual audits as a necessary evaluation standard for medical RL.
Korosh Vatanparvar, Ashutosh Joshi, Maria Xenochristou +11cs.AI cs.CL
Health AI is evolving from answering questions to agentic systems that converse with patients, reason about health records, and act on their behalf. Primary care guards against diagnostic errors and unsafe care; agents assisting in this domain warrant evaluation against the same risks. Current benchmarks focus on medical knowledge, assessed through isolated question-answering or clinician-facing tasks. PatientAgentBench benchmarks patient-facing agentic healthcare; it evaluates a foundation model, wrapped in an agent with a sandbox of healthcare tools, conversing with a simulated patient. Each conversation is scored by an LLM-as-a-Jury across six dimensions via over a hundred conversation-agnostic, clinician-grounded criteria. To validate alignment, licensed clinicians annotated shared conversations, yielding 79-93% adjacent agreement between jury and expert raters, on par with or exceeding clinician inter-rater agreement. We benchmarked 10 models across four families on the same 1,200 scenarios and found clinical gaps. Triage quality is the most discriminating dimension: pass rates rise from 32% for the weakest models to 88% for the strongest, with agents often acting on administrative requests without clinical screening. Clinical safety and workflow accuracy follow the same pattern: the weakest models fail often, fabricating unexecuted actions, while frontier models fail on only 1-3% of cases, from unverified tool outputs and omitted crisis resources in an emergency. More capable models narrow these gaps but do not close them; the strongest scores only 4.25 of 5 overall. These failures surface only in sustained, tool-using conversations against realistic patient records, confirming that static benchmarks are insufficient as healthcare agentic systems gain autonomy. We release the framework as a reproducible, clinician-validated evaluation standard to help the field close this gap.
Safety evaluation of large language models is conducted predominantly in English and predominantly on frontier systems. Neither condition describes how such models are encountered in low-resource health settings, where small quantised systems are run locally and queried in local languages. We ask whether clinical safety established in English transfers to Hausa, and whether any failure is attributable to the language, the clinical task, or the class of model that low-resource deployment admits. Matched English-Hausa question pairs were built for three conditions of high burden in northern Nigeria: malaria, sickle cell disease, and tuberculosis, probing knowledge recall, emergency triage, a leading question inviting a contraindicated action, and a traditional-remedy claim. Six models were evaluated: five locally deployable systems of 4-9 billion parameters, two medically fine-tuned, and one frontier system. All 128 responses were scored against Nigerian national treatment guidelines by two fluent Hausa speakers working independently and blind to one another. Among locally deployable models, mean clinical correctness fell from 1.57 in English to -0.03 in Hausa, on a scale where 2 denotes a correct answer and -1 an actively harmful one. The frontier model moved from 2.00 to 1.75 and produced no response judged harmful in either language. Drift was consistent across all three conditions. Inter-rater agreement was substantial for clinical correctness (kappa = 0.70); agreement on harm was initially poor (kappa = 0.22) and is examined in detail. Because a frontier model answers the same questions competently in Hausa, the deficit is a property neither of the language nor of the clinical material, but of the deployable tier.
Gwydion Williams, Sara Zannone, Bilal A Mateencs.AI
Large language models (LLMs) have become significant providers of mental health support, yet they remain products of an attention economy whose operational and commercial targets favour sustained engagement over the friction that effective psychological support often requires. Developers' safety responses have been largely reactive, addressing the most visible and acute harms while subtler, longer-term patterns of risk (e.g., dependency, boundary erosion, the amplification of distorted beliefs) receive less attention. We contend that making LLMs structurally safe requires alignment organised at three levels that mirror how society assures the safety of human clinical practice: 1) explicit value specification grounded in the codified normative commitments of clinical practice; 2) training that embeds those values in the model; and 3) oversight that detects drift and longer-term harm during deployment, much as clinical supervision does for human practice. Organising alignment in this way yields a construct we call alignment plausibility - a structured demonstration that a system's values, training regime, and oversight mechanisms are together consistent with safe and positive outcomes. We propose alignment plausibility as a regulatory construct (by drawing analogy to the established construct of biological plausibility) for AI in health: a principled way to argue for, or against, trust that systems are aligned to positive health outcomes, will cause no harm even where capable of doing so, and will ultimately lead to patient benefit.
Maria Xenochristou, Ashutosh Joshi, Korosh Vatanparvar +10cs.AI
Recent advances in large language models and vision-language models have enabled reasoning over multimodal data, offering opportunities for clinical applications such as decision support and triaging. However, existing medical AI benchmarks are fragmented: some support multi-turn dialogues but lack images, while others provide multimodal inputs but focus on single-turn QA tasks. To address this gap, we introduce IMCBench, an image-grounded, multi-turn medical conversation benchmark that pairs real, publicly available clinical images with synthetic patient profiles to simulate realistic patient-clinician interactions. Each conversation is evaluated across three clinical dimensions: safety, accuracy, and appropriate use of uncertainty in diagnosis. We benchmark eight multimodal frontier models across four model families (Claude, GPT, Nova, and Llama), scoring each on a 1-5 scale using LLM-as-Jury scoring calibrated against expert clinician annotations. Our results show that Claude Opus 4.6 achieves the highest overall score (3.61), followed by Claude Sonnet 4.6 (3.30) and GPT-5.2 (3.29), though no model dominates all dimensions and safety degrades for both malignant and rare conditions ($Δ$ = -0.27 each). Ablation studies further reveal that both visual input and EHR context contribute to safe guidance (safety drops of 0.18 and 0.23 on average when each is removed), with stronger models leveraging visual features more effectively. Together, these findings demonstrate that accurate clinical description does not guarantee safe patient guidance, motivating the need for multi-dimensional evaluation frameworks in medical AI.
Muhammad Osama, Maheera Amjad, Zartasha Mustansar +2cs.LG
Large Language Models (LLMs) are increasingly deployed in healthcare settings, yet their tendency to hallucinate poses risks when clinical decisions are involved. This study examine whether LLMs recommend recently banned or withdrawn pharmaceuticals when answering clinical questions and tests an agent-based method for reducing such errors. We developed a five-agent "Trust but Verify" system using a single LLM backbone. To measure regulatory knowledge obsolescence, we created an adversarial dataset of 103 clinical MCQs where historically correct answers now refer to banned substances. This scale ensures statistical significance across various therapeutic classes. We evaluated three open-access model families (GPT-OSS, Llama-3, Falcon-3) under vanilla and agentic conditions. Performance was measured via pointwise score, label accuracy, Hallucination Error Rate (HER), and Component Fidelity (CF) score. We also observed clinical safety regression in proprietary models. In default configurations, all models showed high hallucination rates, consistently selecting banned drugs that matched training data patterns. Our proposed agentic architecture reduced HER by approximately 53% across models. Pointwise scores shifted from -0.25 (unsafe recommendation) toward 0.0 (appropriate refusal). The safety audit intercepted dangerous outputs even when models' parametric knowledge favored the banned substance. The proposed multi-agent framework offers a model-agnostic method for enforcing regulatory compliance that prioritizes patient safety over fluent text generation. Our work demonstrates a practical approach for deploying autonomous AI systems in safety-critical healthcare settings. It shows how real-time regulatory data can be integrated into LLM pipelines to support clinical decision-making.